Terug
Dagbereik
€ 146,61
€ 153,48
52-Weeksbereik
€ 49,00
€ 200,00
Volume
172.006
50D / 200D Gem.
€ 170,97
/
€ 110,33
Vorige Slotkoers
€ 151,14
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -76,5 | 0,4 |
| P/B | 40,7 | 2,9 |
| ROE % | -65,7 | 3,9 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 203,00
+34.6%
Low: € 187,00
High: € 223,00
Forward WPA
-€ 2,14
Omzet Sch.
26 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 22,07
€ 14,56 – € 42,72
|
1,4 B | 2 |
| FY2029 |
€ 16,14
€ 10,65 – € 31,23
|
990 M | 2 |
| FY2028 |
€ 8,66
€ 2,62 – € 21,95
|
560 M | 4 |
Belangrijkste Punten
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -29,39M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-65,70%
ROIC-43,15%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,00
Current Ratio24,31
Interest Coverage0,00
Waardering
P/E Ratio
-76,45
P/B Ratio40,69
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -77,61M |
| ROE | -65,70% | ROA | -51,02% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -29,39M |
| ROIC | -43,15% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 24,31 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -76,45 | P/B Ratio | 40,69 |
| P/S Ratio | N/A | PEG Ratio | -0,72 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 5,93B | Enterprise Value | 5,90B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -77,61M | -36,14M | -31,63M | -12,65M | -9,67M |
| EPS (Diluted) | -2,31 | -1,18 | -1,19 | -0,63 | -0,40 |
| Gross Profit | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -84,21M | -40,00M | -31,67M | -12,82M | -9,80M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 152,13M | 94,64M | 44,27M | 18,35M | 25,74M |
| Total Liabilities | 6,31M | 4,21M | 2,77M | 33,44M | 32,78M |
| Shareholders' Equity | 145,82M | 90,43M | 41,50M | -15,09M | -7,04M |
| Total Debt | 537.000,0 | 886.000,0 | 866.000,0 | 31,81M | 31,81M |
| Cash & Equivalents | 31,68M | 88,16M | 42,09M | 17,34M | 25,62M |
| Current Assets | 147,07M | 89,94M | 42,81M | 17,43M | 25,67M |
| Current Liabilities | 6,05M | 3,63M | 2,10M | 1,64M | 972.000,0 |